Atrial fibrillation in the older adult. Presentation and management issues.
暂无分享,去创建一个
[1] C. M. Hudak,et al. Critical care nursing : a holistic approach , 1994 .
[2] Palle Petersen,et al. PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.
[3] A Laupacis,et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.
[4] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[5] P. Sloane,et al. Clinical Efficacy and Outcome in the Diagnosis and Treatment of Low Back Pain , 1992, Neurology.
[6] M. Monane,et al. Pharmacotherapy: strategies to control drug costs in managed care. , 1998, Geriatrics.
[7] J. Whittle,et al. Is warfarin underused in the treatment of elderly persons with atrial fibrillation? , 1997, Archives of internal medicine.
[8] S. Connolly,et al. Stroke prevention in nonvalvular atrial fibrillation. , 1991, Annals of internal medicine.
[9] R B D'Agostino,et al. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. , 1996, American heart journal.
[10] J. Anderson,et al. Acute treatment of atrial fibrillation and flutter. , 1996, The American journal of cardiology.
[11] V. Salomaa,et al. Atrial Fibrillation in Older Stroke Patients: Association with Recurrence and Mortality After First Ischemic Stroke , 1997, Journal of the American Geriatrics Society.
[12] Z. J. Lipowski. Letter: Psychosomatic medicine. , 1974, Lancet.
[13] Emmett Kr,et al. Nonspecific and atypical presentation of disease in the older patient. , 1998 .
[14] Joseph T. DiPiro,et al. Pharmacotherapy: A pathophysiologic approach , 1992 .